United States · Federal contract register · Supplier record

VQ BIOMEDICAL, INC

Line: Health r&d services; health care services; experimental development (AN13)Register loaded to September 2026Compiled 6 October 2026

VQ BIOMEDICAL, INC — United States · Federal contract register · Supplier record: 1 contracts, all years ($749,900 · Jul 2024 – Jul 2024); $750K since January 2024 (1 contract · 1 agency); 46th rank in the line (of 102 suppliers · 0.13%); 3 agencies never served ($80.8M on the line without VQ BIOMEDICAL, INC).

Assay record ASY-US-1DHTSDA1V1 · Cite as: Assay Systems, “VQ BIOMEDICAL, INC in the USAspending register”, https://assay-systems.com/register/us/vq-biomedical-inc/

1
contracts, all years
$749,900 · Jul 2024 – Jul 2024
$750K
since January 2024
1 contract · 1 agency
46th
rank in the line
of 102 suppliers · 0.13%
3
agencies never served
$80.8M on the line without VQ BIOMEDICAL, INC

Own record by year

2024 onward
$750K
202420252026

Who buys from VQ BIOMEDICAL, INC

since January 2024
1agencies
$750Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$749,900

The line

since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten

Health r&d services; health care services; experimental development (AN13)

$239M
$109M
$218M
202420252026Jan–Sep
46thof 102 suppliers
$749,900VQ BIOMEDICAL, INC in the line
0.13%share of the line
0.2%of $485,502,671 spent by Department of Health and Human Services

Agencies that buy the line and never bought from VQ BIOMEDICAL, INC

3agencies
61contracts
$80,752,756since January 2024
Department of Defense18 contracts
$50,693,667
Department of the Interior17 contracts
$26,151,140
Department of Veterans Affairs26 contracts
$3,907,948

How the line is bought

by value, since 2024
3%no competition
69%one applicant
0of these to VQ BIOMEDICAL, INC
Competed, one supplier applied40 contracts
$392,806,182 · 69.4%
Competed, several suppliers applied54 contracts
$155,897,480 · 27.5%
Awarded directly, no competition30 contracts
$17,551,765 · 3.1%

Contracts reaching their end dates

Oct 2026 – October 2027
35contracts
$69,818,385end by October 2027
10end in September 2027 · $35.6M
21in agencies never served · $28.0M
$1.5M
$1.8M
$69.8K
$1.4M
$1.5M
$13.1M
$186K
$2.0M
$12.6M
$35.6M
Oct 262 contractsNov 263 contractsDec 261 contractJan 271 contractFeb 273 contractsMar 2710 contractsMay 271 contractJun 271 contractAug 273 contractsSep 2710 contracts

Suppliers next to it in the line

since January 2024
CAPTURE BIOSCIENCE INC.1 contract · 1 agency
$749,999
VQ BIOMEDICAL, INC
$749,900
MACH32 INC1 contract · 1 agency
$749,846
GNOMX CORP.1 contract · 1 agency
$749,700

All 102 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.